Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene and PUVA vs PUVA in Mycosis Fungoides
NCT00056056Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jan 2003
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 13
01
Overview
A Phase 3 trial of bexarotene in mycosis fungoides (MF), sponsored by European Organisation for Research and Treatment of Cancer. Started Jan 2003; status: terminated.
02
Drugs
bexarotene
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT00056056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056056.